The FDA approved budesonide/glycopyrrolate/formoterol fumarate (Breztri Aerosphere) in a single inhaler as maintenance ...
After breaking through the blockbuster sales threshold in 2025, AstraZeneca’s three-in-one inhaler Breztri Aerosphere has ...
The FDA approved Breztri Aerosphere, a single-inhaler triple therapy, as a maintenance treatment for patients aged at least ...
Unexpected asthma triggers can include thirdhand smoke, weather changes, certain chemicals, strong fragrances, wood smoke, ...
A machine learning model slightly outperforms a conventional regression model at predicting which children hospitalized for asthma will be readmitted within 180 days.
9h
Researchers deepen understanding of molecular pathways responsible for airway inflammation in asthma
Johns Hopkins Medicine researchers say they have identified molecular pathways controlled by the protein RhoA in club cells—a ...
FDA approves Breztri Aerosphere for asthma, introducing the first single-inhaler triple-combination maintenance therapy for ...
A new asthma drug, Lunsekimig, is showing promise in reducing inhaler dependence. Early trials report fewer symptoms, improved lung function, and reduced attacks. Unlike inhalers, it targets ...
A new study published in the Journal of the American Medical Association (JAMA) found 33 per cent of adults recently diagnosed with asthma by their physicians did not have an active form of the ...
GLP-1 receptor agonists reduced asthma exacerbations among adults with asthma and excess weight but without diabetes in ...
AstraZeneca has scrapped an asthma program after the FLAP inhibitor flopped in a phase 2 trial. | AstraZeneca has scrapped an ...
Depressive symptoms are common in people with asthma, but increasing evidence suggests they may be driven by biological processes that differ from those seen in major depressive disorder.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results